These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 26090398)

  • 21. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].
    Xie XT; Jiang SY; Li BS; Yang LL
    Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):276-80. PubMed ID: 19099730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDA gene polymorphisms and enzyme activity: genotype-phenotype relationship in an Italian-Caucasian population.
    Carpi FM; Vincenzetti S; Ubaldi J; Pucciarelli S; Polzonetti V; Micozzi D; Mignini F; Napolioni V
    Pharmacogenomics; 2013 May; 14(7):769-81. PubMed ID: 23651026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia.
    Xu PP; Chen BA; Feng JF; Cheng L; Xia GH; Li YF; Qian J; Ding JH; Lu ZH; Wang XM; Xu K; Schultz M
    Chin Med J (Engl); 2012 Jun; 125(12):2137-43. PubMed ID: 22884143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment outcome in older patients with childhood acute myeloid leukemia.
    Rubnitz JE; Pounds S; Cao X; Jenkins L; Dahl G; Bowman WP; Taub JW; Pui CH; Ribeiro RC; Campana D; Inaba H
    Cancer; 2012 Dec; 118(24):6253-9. PubMed ID: 22674050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment-related mortality in children with acute myeloid leukaemia in Central America: incidence, timing and predictors.
    Gupta S; Bonilla M; Valverde P; Fu L; Howard SC; Ribeiro RC; Sung L
    Eur J Cancer; 2012 Jun; 48(9):1363-9. PubMed ID: 22082459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variability in transport and biotransformation of cytarabine is associated with its toxicity in peripheral blood mononuclear cells.
    Parmar S; Seeringer A; Denich D; Gärtner F; Pitterle K; Syrovets T; Ohmle B; Stingl JC
    Pharmacogenomics; 2011 Apr; 12(4):503-14. PubMed ID: 21521023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate.
    Abrahamsson J; Forestier E; Heldrup J; Jahnukainen K; Jónsson OG; Lausen B; Palle J; Zeller B; Hasle H
    J Clin Oncol; 2011 Jan; 29(3):310-5. PubMed ID: 21149663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of genetic alterations of cytarabine- metabolizing enzymes in childhood acute lymphoblastic leukemia.
    Banklau C; Jindadamrongwech S; Sawangpanich R; Apibal S; Hongeng S; Paisooksantivatana K; Pakakasama S
    Hematol Oncol Stem Cell Ther; 2010; 3(3):103-8. PubMed ID: 20890066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethnic differences of two non-synonymous single nucleotide polymorphisms in CDA gene.
    Sugiyama E; Lee SJ; Lee SS; Kim WY; Kim SR; Tohkin M; Hasegawa R; Okuda H; Kawamoto M; Kamatani N; Sawada J; Kaniwa N; Saito Y; Shin JG
    Drug Metab Pharmacokinet; 2009; 24(6):553-6. PubMed ID: 20045991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PCR-based methods for CDA K27Q and A70T genotyping: genotypes and alleles distribution in a central Italy population.
    Carpi FM; Vincenzetti S; Micozzi D; Vita A; Napolioni V
    Mol Biol Rep; 2010 Oct; 37(7):3363-8. PubMed ID: 19941076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival.
    Mahlknecht U; Dransfeld CL; Bulut N; Kramer M; Thiede C; Ehninger G; Schaich M
    Leukemia; 2009 Oct; 23(10):1929-32. PubMed ID: 19458626
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia.
    Bhatla D; Gerbing RB; Alonzo TA; Conner H; Ross JA; Meshinchi S; Zhai X; Zamzow T; Mehta PA; Geiger H; Perentesis J; Davies SM
    Br J Haematol; 2009 Feb; 144(3):388-94. PubMed ID: 19036079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential allelic expression in leukoblast from patients with acute myeloid leukemia suggests genetic regulation of CDA, DCK, NT5C2, NT5C3, and TP53.
    Jordheim LP; Nguyen-Dumont T; Thomas X; Dumontet C; Tavtigian SV
    Drug Metab Dispos; 2008 Dec; 36(12):2419-23. PubMed ID: 18775979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics.
    Kocabas NA; Aksoy P; Pelleymounter LL; Moon I; Ryu JS; Gilbert JA; Salavaggione OE; Eckloff BW; Wieben ED; Yee V; Weinshilboum RM; Ames MM
    Drug Metab Dispos; 2008 Sep; 36(9):1951-9. PubMed ID: 18556440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.
    Tibaldi C; Giovannetti E; Vasile E; Mey V; Laan AC; Nannizzi S; Di Marsico R; Antonuzzo A; Orlandini C; Ricciardi S; Del Tacca M; Peters GJ; Falcone A; Danesi R
    Clin Cancer Res; 2008 Mar; 14(6):1797-803. PubMed ID: 18347182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.
    Lange BJ; Smith FO; Feusner J; Barnard DR; Dinndorf P; Feig S; Heerema NA; Arndt C; Arceci RJ; Seibel N; Weiman M; Dusenbery K; Shannon K; Luna-Fineman S; Gerbing RB; Alonzo TA
    Blood; 2008 Feb; 111(3):1044-53. PubMed ID: 18000167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicapillary electrophoresis analysis of single-nucleotide sequence variations in the deoxycytidine kinase gene.
    Szantai E; Ronai Z; Sasvari-Szekely M; Bonn G; Guttman A
    Clin Chem; 2006 Sep; 52(9):1756-62. PubMed ID: 16858072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteers.
    Joerger M; Bosch TM; Doodeman VD; Beijnen JH; Smits PH; Schellens JH
    Eur J Clin Pharmacol; 2006 Aug; 62(8):681-4. PubMed ID: 16799820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics.
    Gilbert JA; Salavaggione OE; Ji Y; Pelleymounter LL; Eckloff BW; Wieben ED; Ames MM; Weinshilboum RM
    Clin Cancer Res; 2006 Mar; 12(6):1794-803. PubMed ID: 16551864
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.